日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

Russia tests Avifavir anti-coronavirus drug

Xinhua | Updated: 2020-06-02 09:46
Share
Share - WeChat
Tablets of Avigan (generic name : Favipiravir), a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. [Photo/Agencies]

MOSCOW - Russia is currently carrying out clinical tests of Avifavir, which may prove to be an efficient treatment for COVID-19, the producer of the drug said in a statement on Monday.

"Avifavir is the first direct-acting antiviral drug registered in Russia that has proven effective against COVID-19 in clinical trials," ChemRar Group said in a statement.

Avifavir is produced by a joint venture of the Russian Direct Investment Fund, Russia's sovereign wealth fund, and ChemRar Group, which includes research and development services and investment companies in the field of innovative pharmaceuticals.

The final stage of Avifavir clinical trials involving 330 patients, approved by the Russian Health Ministry on May 21, is ongoing, the statement said.

Efficacy of the drug is above 80 percent, a criterion for a drug with high antiviral activity, it said.

Following the first four days of treatment, 65 percent of the 40 patients who took Avifavir tested negative for coronavirus, which is twice as many as in the standard therapy group, the statement said.

By day 10, the number of patients whose tests returned negative results reached 90 percent, it added.

Avifavir has received a registration certificate from the Russian Health Ministry, thus becoming the first Favipiravir-based drug in the world approved for the treatment of COVID-19, according to the statement.

Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan since 2014.

In early June, the first batches of Avifavir will be sent to Russia's Federal Service for Surveillance in Healthcare for approval for use, the statement said.

Deliveries of the first batches of the drug to Russian hospitals are expected on June 11, it added.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 草综合| 成人做爰高潮片免费视频韩国 | 日韩视频久久 | 在线观看亚洲a | 婷婷精品| 国产片翁熄系列乱在线视频 | 一级片免费播放 | 亚洲高清在线看 | 王的女人印度剧电视剧免费观看32集 | 亚洲第一成人在线 | 亚洲狠狠婷婷综合久久蜜桃 | 久久久精品影院 | 久久婷婷是五月综合色狠狠 | 色综合久久亚洲国产日韩 | 亚洲精品美女久久久 | 91 在线| 久久人人爽人人爽 | 亚洲精品久久久蜜桃 | 天海翼视频在线 | 亚洲免费观看视频 | 日本在线观看中文字幕 | 太平公主一级艳史播放高清 | 久久精品91久久久久久再现 | 国产区视频在线观看 | 贺鹏个人资料 | 免费v片在线观看 | 欧美日一区 | 97久久国语露脸精品对白 | 免费久久99精品国产婷婷六月 | 免费国产精品视频在线 | 91精品国产日韩91久久久久久 | 亚洲一区二区三区在线视频 | 王骏迪的个人资料 | 国产婷婷 | 奇米影视在线视频 | 欧美日韩综合视频 | 天天操天天拍 | 午夜精品| 网红主播vip福利视频 | 欧美日韩在线一区二区三区 | 国内一级特黄女人精品片 |